glp 1 name How GLP-1 medications are transforming diabetes and weight loss treatment Glucagon-like peptide-1 - Wikipedia

In a 6-month study of type 1 diabetes patients, 79% of patients who received TOUJEO once daily were positive for anti-insulin antibodies (AIA) at least once during the study, including 62% that were positive at baseline and 44% of patients who developed antidrug antibody (i.e., anti-insulin glargine antibody [ADA]) during the study

Use as directed and store in a cool, dry place

10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure

Thorax 48 959966

Weeks 1-4: Initial Phase During the first month, Tirzepatide effects begin manifesting

Blase E, Taylor K, Gao HY, Wintle M, Fineman M